Baijin Life Science Holdings Limited, an investment holding company, engages in the purchase, process, design, production, and wholesale distribution of pearls and jewelry products. It operates through Sales of Pearls and Jewellery Products; Strategic Investment and Financial Services; Skincare Solutions; Research and Development Services; and Brand Marketing and Consulting Services segment. The company is also involved in the real estate financial assets investment business. In addition, it offers skincare solutions products under the FO brand name to cosmetics stores and hospitals through sales contracts, as well as individuals through online sales platforms. Further, the company provides scientific and pharmaceutical research and development services; and brand marketing and consulting services. It operates in Hong Kong, the People’s Republic of China, the United States, Europe, and Asia. The company was formerly known as Affluent Partners Holdings Limited and changed its name to Baijin Life Science Holdings Limited in January 2025. Baijin Life Science Holdings Limited was incorporated in 2014 and is based in Wan Chai, Hong Kong.